Research Project Grant (Parent R01 Clinical Trial Not Allowed) is a flagship NIH grant administered by the National Institute of Allergy and Infectious Diseases that funds investigator-initiated biomedical and behavioral research projects not involving clinical trials. The R01 supports hypothesis-driven research across a wide range of health topics including infectious diseases, immune disorders, and allergy-related conditions. Eligible applicants include higher education institutions such as public and private universities. Award amounts range from $250,000 to $2,500,000 with a deadline of June 5, 2026.

Tuberculosis Research Advancement Centers (TRACs) (P30 Clinical Trial Not Allowed) is sponsored by National Institute of Allergy and Infectious Diseases (NIAID). This program supports the establishment of Tuberculosis (TB) Research Advancement Centers (TRACs) to develop the next generation of TB researchers and catalyze multidisciplinary and innovative TB science by providing expertise and resources to facilitate basic and clinical TB re…

NCI Continuing Umbrella of Research Experiences (CURE) Academic Career Excellence (ACE) Award (K32) is a grant from the National Cancer Institute (NCI) that funds early postdoctoral fellows from diverse backgrounds, including underrepresented groups, to pursue research training in cancer-related fields. The K32 award supports fellows within 12 months prior to transitioning into, or within the first two years of, a postdoctoral position. The program, operated through NCI's Center to Reduce Cancer Health Disparities (CRCHD), aims to enhance the pool of qualified diverse cancer researchers. Beginning with the June 12, 2025 due date, the CURE ACE Award is available in both Independent Clinical Trial Required and Independent Clinical Trial Not Allowed versions. Eligible applicants must be U.S. citizens or permanent residents at time of award.